WANG, X., V. S. PANKRATZ, Z. FREDERICKSEN, R. TARRELL, M. KARAUS, L. MCGUFFOG, Paul D. P. PHARAOH, B. PONDER, A.M. DUNNING, S. PEOCK, M. COOK, C. OLIVER, D. FROST, O. SINILNIKOVA, D. STOPPA-LYONNET, S. MAZOYER, C. HOUDAYER, Frans B. L. HOGERVORST, M. HOONING, M. LIGTENBERG, A. SPURDLE, G. CHENEVIX-TRENCH, R. SCHMUTZLER, B. WAPPENSCHMIDT, Ch. ENGEL, A. MEINDL, S. DOMCHEK, K. NATHANSON, T. REBBECK, Ch. SINGER, D. GSCHWANTLER-KAULICH, C. DRESSLER, A. FINK, C. SZABO, M. ZIKAN, Lenka FORETOVÁ, K. CLAES, G. THOMAS, R. HOOVER, D. HUNTER, S. CHANOCK, D. EASTON, A. ANTONIOU and F. COUCH. Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. Human molecular genetics. 2010, vol. 19, No 14, p. 2886-2897. ISSN 0964-6906. Available from: https://dx.doi.org/10.1093/hmg/ddq174.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers
Authors WANG, X. (826 United Kingdom of Great Britain and Northern Ireland, guarantor), V. S. PANKRATZ (826 United Kingdom of Great Britain and Northern Ireland), Z. FREDERICKSEN (826 United Kingdom of Great Britain and Northern Ireland), R. TARRELL (826 United Kingdom of Great Britain and Northern Ireland), M. KARAUS (826 United Kingdom of Great Britain and Northern Ireland), L. MCGUFFOG (826 United Kingdom of Great Britain and Northern Ireland), Paul D. P. PHARAOH (826 United Kingdom of Great Britain and Northern Ireland), B. PONDER (826 United Kingdom of Great Britain and Northern Ireland), A.M. DUNNING (826 United Kingdom of Great Britain and Northern Ireland), S. PEOCK (826 United Kingdom of Great Britain and Northern Ireland), M. COOK (826 United Kingdom of Great Britain and Northern Ireland), C. OLIVER (826 United Kingdom of Great Britain and Northern Ireland), D. FROST (826 United Kingdom of Great Britain and Northern Ireland), O. SINILNIKOVA (250 France), D. STOPPA-LYONNET (250 France), S. MAZOYER (250 France), C. HOUDAYER (250 France), Frans B. L. HOGERVORST (528 Netherlands), M. HOONING (528 Netherlands), M. LIGTENBERG (528 Netherlands), A. SPURDLE (528 Netherlands), G. CHENEVIX-TRENCH (528 Netherlands), R. SCHMUTZLER (276 Germany), B. WAPPENSCHMIDT (276 Germany), Ch. ENGEL (276 Germany), A. MEINDL (276 Germany), S. DOMCHEK (840 United States of America), K. NATHANSON (840 United States of America), T. REBBECK (40 Austria), Ch. SINGER (40 Austria), D. GSCHWANTLER-KAULICH (40 Austria), C. DRESSLER (40 Austria), A. FINK (40 Austria), C. SZABO (40 Austria), M. ZIKAN (203 Czech Republic), Lenka FORETOVÁ (203 Czech Republic, belonging to the institution), K. CLAES (56 Belgium), G. THOMAS (840 United States of America), R. HOOVER (840 United States of America), D. HUNTER (840 United States of America), S. CHANOCK (840 United States of America), D. EASTON (826 United Kingdom of Great Britain and Northern Ireland), A. ANTONIOU (826 United Kingdom of Great Britain and Northern Ireland) and F. COUCH (840 United States of America).
Edition Human molecular genetics, 2010, 0964-6906.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher United Kingdom of Great Britain and Northern Ireland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 8.058
RIV identification code RIV/00216224:14110/10:00051819
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1093/hmg/ddq174
UT WoS 000279469100013
Keywords in English ESTROGEN-RECEPTOR; CONFER SUSCEPTIBILITY; GENETIC-VARIATION; ALLELES; PREDISPOSITION; INVESTIGATORS; POLYMORPHISM; CONSORTIUM; COMPLEX; MODEL
Tags International impact
Changed by Changed by: Mgr. Michal Petr, učo 65024. Changed: 12/4/2012 15:18.
Abstract
Recent studies have identified single nucleotide polymorphisms (SNPs) that significantly modify breast cancer risk in BRCA1 and BRCA2 mutation carriers. Since these risk modifiers were originally identified as genetic risk factors for breast cancer in genome-wide association studies (GWASs), additional risk modifiers for BRCA1 and BRCA2 may be identified from promising signals discovered in breast cancer GWAS. A total of 350 SNPs identified as candidate breast cancer risk factors (P < 1 x 10(-3)) in two breast cancer GWAS studies were genotyped in 3451 BRCA1 and 2006 BRCA2 mutation carriers from nine centers. Associations with breast cancer risk were assessed using Cox models weighted for penetrance. Eight SNPs in BRCA1 carriers and 12 SNPs in BRCA2 carriers, representing an enrichment over the number expected, were significantly associated with breast cancer risk (P(trend) < 0.01). The minor alleles of rs6138178 in SNRPB and rs6602595 in CAMK1D displayed the strongest associations in BRCA1 carriers (HR = 0.78, 95% CI: 0.69-0.90, P(trend) = 3.6 x 10(-4) and HR = 1.25, 95% CI: 1.10-1.41, P(trend) = 4.2 x 10(-4)), whereas rs9393597 in LOC134997 and rs12652447 in FBXL7 showed the strongest associations in BRCA2 carriers (HR = 1.55, 95% CI: 1.25-1.92, P(trend) = 6 x 10(-5) and HR = 1.37, 95% CI: 1.16-1.62, P(trend) = 1.7 x 10(-4)). The magnitude and direction of the associations were consistent with the original GWAS. In subsequent risk assessment studies, the loci appeared to interact multiplicatively for breast cancer risk in BRCA1 and BRCA2 carriers. Promising candidate SNPs from GWAS were identified as modifiers of breast cancer risk in BRCA1 and BRCA2 carriers. Upon further validation, these SNPs together with other genetic and environmental factors may improve breast cancer risk assessment in these populations.
PrintDisplayed: 28/5/2024 15:49